BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8701792)

  • 1. Relative resistance of a macroprolactinoma to bromocriptine therapy during pregnancy.
    Shanis BS; Check JH
    Gynecol Endocrinol; 1996 Apr; 10(2):91-4. PubMed ID: 8701792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
    Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy in a patient with prolactinoma off treatment.
    Sood A; Kalra S; Gulati MS; Mittal S
    J Assoc Physicians India; 2000 Dec; 48(12):1221. PubMed ID: 11280238
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of a large macroprolactinoma with cabergoline during pregnancy.
    Liu C; Tyrrell JB
    Pituitary; 2001 Aug; 4(3):179-85. PubMed ID: 12138991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of prolactinoma growth during pregnancy. Visual field tests required in macroadenoma, small risk in microadenomas].
    Ericsson C; Lindblom B
    Lakartidningen; 2012 Jun 19-26; 109(25):1226-8. PubMed ID: 22838112
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolactinoma and pregnancy.
    Randeva HS; Davis M; Prelevic GM
    BJOG; 2000 Sep; 107(9):1064-8. PubMed ID: 11002946
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
    Querol Ripoll R; Cámara Gómez R; Del Olmo García M; Simal Julián JA; Merino Torres JF
    Endocrinol Nutr; 2015 Apr; 62(4):200-2. PubMed ID: 25732323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of bromocriptine during pregnancy and appearance of partial empty sella turcica in women with prolactinoma].
    López de la Torre Casares M; Rodríguez Poyo-Guerrero P; Garrido Pérez M; Moreno Esteban B
    Rev Clin Esp; 1991 Nov; 189(7):343-4. PubMed ID: 1767093
    [No Abstract]   [Full Text] [Related]  

  • 9. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.
    Badawy SZ; Marziale JC; Rosenbaum AE; Chang JK; Joy SE
    Early Pregnancy; 1997 Dec; 3(4):306-11. PubMed ID: 10086082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
    Košec A; Kruljac I; Ajduk J
    Am J Audiol; 2019 Sep; 28(3):548-552. PubMed ID: 31430172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.
    Ahmed M; al-Dossary E; Woodhouse NJ
    Fertil Steril; 1992 Sep; 58(3):492-7. PubMed ID: 1521641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis and prolactinoma.
    Kararizou E; Stamboulis E; Markou I; Alevizaki M; Gkiatas K
    Funct Neurol; 2007; 22(1):39-41. PubMed ID: 17509242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes.
    Oshige T; Nakamura Y; Sasaki Y; Kawano S; Ohki T; Tsuruta M; Tokubuchi I; Nakayama H; Yamada K; Ashida K; Tajiri Y; Nomura M
    Intern Med; 2019 Nov; 58(21):3125-3128. PubMed ID: 31243214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.
    Tan SL; Jacobs HS
    Int J Gynaecol Obstet; 1986 Jun; 24(3):209-15. PubMed ID: 2880760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine-induced brainstem angulation in a patient with invasive prolactinoma.
    Lou XH; Wu ZB; Zhang YZ
    J Clin Endocrinol Metab; 2013 Mar; 98(3):867-8. PubMed ID: 23365124
    [No Abstract]   [Full Text] [Related]  

  • 16. Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.
    Bergh T; Nillius SJ; Enoksson P; Wide L
    J Endocrinol Invest; 1984 Apr; 7(2):133-6. PubMed ID: 6725868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic hypertrophic pachymeningitis mimicking prolactinoma with recurrent vision loss.
    Lok JY; Yip NK; Chong KK; Li CL; Young AL
    Hong Kong Med J; 2015 Aug; 21(4):360-2. PubMed ID: 26238133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: rapid regression of symptoms under bromocriptine. Case reports.
    Crosignani P; Ferrari C; Mattei AM
    Br J Obstet Gynaecol; 1984 Aug; 91(8):821-3. PubMed ID: 6466586
    [No Abstract]   [Full Text] [Related]  

  • 19. A rare case of pregnancy and delivery of a healthy neonate by a woman with microprolactinoma and review of the literature.
    Kwaśniewska A; Skoczyński M; Semczuk M
    Clin Exp Obstet Gynecol; 2004; 31(4):309-10. PubMed ID: 15672976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
    Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.